Costa E, Buxton J, Brown J, Templeton K E, Breuer J, Johannessen I
Royal Infirmary of Edinburgh, Edinburgh, UK.
Borders General Hospital, Melrose, UK.
BMJ Case Rep. 2016 May 4;2016:bcr2015212688. doi: 10.1136/bcr-2015-212688.
A 79-year-old man with chronic lymphocytic leukaemia presented with fever and a widespread vesicular rash on 19 November 2014. The patient had not been under immunosuppressive regime for 6 months. He had received a shingles vaccine on 14th October and developed flu-like symptoms after 2 weeks. Intravenous antimicrobial therapy including aciclovir was started. He remained stable with no evidence of systemic involvement. On day 5, he developed respiratory and renal failure that required transfer to intensive care unit. Vesicle fluid, bronchoalveolar lavage and plasma were positive for varicella zoster virus by PCR. Slight clinical improvement allowed extubation on day 16. He subsequently deteriorated and died on day 25. Multiorgan failure was considered the immediate cause of death whereas disseminated varicella zoster infection was stated in the medical certificate as the other condition leading to this outcome. Varicella zoster Oka vaccine strain was detected in vesicle fluid, using PCR.
一名79岁的慢性淋巴细胞白血病男性患者于2014年11月19日出现发热及广泛的水疱疹。患者已6个月未接受免疫抑制治疗。他于10月14日接种了带状疱疹疫苗,2周后出现流感样症状。开始了包括阿昔洛韦在内的静脉抗菌治疗。他病情保持稳定,无全身受累迹象。第5天,他出现呼吸和肾衰竭,需要转入重症监护病房。通过聚合酶链反应(PCR)检测,水疱液、支气管肺泡灌洗物和血浆中水痘带状疱疹病毒呈阳性。第16天,轻微的临床改善使患者得以拔管。随后他病情恶化,于第25天死亡。多器官功能衰竭被认为是直接死因,而医疗证明中指出播散性水痘带状疱疹感染是导致这一结果的另一情况。使用PCR在水疱液中检测到水痘带状疱疹Oka疫苗株。